ACPT-I is primarily utilized in neuroscience research to study the mechanisms of synaptic transmission and plasticity. It acts as a selective agonist for group I metabotropic glutamate receptors (mGluRs), which are crucial for modulating neuronal excitability and synaptic strength. By activating these receptors, ACPT-I helps researchers investigate the role of mGluRs in various neurological processes, including learning, memory, and neurodevelopmental disorders. Additionally, it is used in experimental models to explore potential therapeutic targets for conditions such as epilepsy, anxiety, and neurodegenerative diseases. Its application in these studies provides valuable insights into the functioning of the central nervous system and the development of novel treatments for brain-related disorders.